 |
|
Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A
A Comparison of 2 Protocols
Paul J. Drinka, MD;
Stefan Gravenstein, MD;
Margo Schilling, MD;
Peggy Krause, RN;
Barbara A. Miller, RN;
Peter Shult, PhD
Arch Intern Med. 1998;158:2155-2159.
Background We performed a randomized trial of 2 protocols guiding the duration of antiviral chemoprophylaxis during outbreaks of influenza A in a rural, 700-bed nursing home for veterans and their spouses with 14 nursing units in 4 buildings.
Methods Half of all residents volunteered to participate. Nursing units were randomized, and the effectiveness of short-term (minimum, 14 days and 7 days without the onset of a case in the building) vs long-term (minimum, 21 days and 7 days without the onset of a case in the 4-building facility) prophylaxis was compared using amantadine hydrochloride in the influenza seasons of 1991-1992 and 1993-1994 and rimantadine hydrochloride in the influenza season of 1994-1995. A "case" is defined as an incident of a respiratory tract illness and the isolation of an influenza virus organism. We compared the number of cases after the discontinuation of short vs long-term chemoprophylaxis. Prospective surveillance identified residents with new respiratory tract symptoms, and specimens for viral cultures were obtained even in the absence of temperature elevation.
Results We documented influenza A virus activity during 3 seasons (32, 68, and 12 patients, respectively). During the 1991-1992, 1993-1994, and 1994-1995 influenza seasons, the patients on 11 floors were assigned to receive short-term chemoprophylaxis and those on 10 floors were assigned to long-term chemoprophylaxis. Only in 1993-1994 did chemoprophylaxis extend beyond 14 or 21 days when new cases continued beyond 14 days. Amantadine-resistant strains were circulating at that time. None of the participants in the prospective, controlled study had influenza develop after the termination of short- or long-term chemoprophylaxis.
Conclusion Antiviral chemoprophylaxis can be administered for the longer duration of 14 days or, in the absence of new culture-confirmed illness in the nursing building, for 7 days.
From the Office of the Medical Director (Dr Drinka) and the Research Institute (Ms Krause), Wisconsin Veterans Home, King; the Department of Internal Medicine–Geriatrics (Dr Drinka) and the Institute on Aging and Adult Life (Ms Miller), University of Wisconsin School of Medicine, Madison; the Department of Internal Medicine–Geriatrics, Glennan Center for Geriatrics and Gerontology, Eastern Virginia Medical School, Norfolk (Drs Gravenstein and Schilling); and Communicable Diseases Division, State Laboratory of Hygiene, Madison, Wis (Dr Shult).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Prevention and Treatment of Influenza
Couch
NEJM 2000;343:1778-1787.
FULL TEXT
|
